Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Net Sales Growth

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Net Sales Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Net Sales Growth(%) 12.771.98-5.8612.442.85

What is the latest Net Sales Growth ratio of GLENMARK PHARMACEUTICALS ?

The latest Net Sales Growth ratio of GLENMARK PHARMACEUTICALS is 12.77 based on Mar2025 Consolidated results.
Year Net Sales Growth
Mar202512.77
Mar20241.98
Mar2023-5.86
Mar202212.44
Mar20212.85

How is Net Sales Growth of GLENMARK PHARMACEUTICALS Trending?

Years Net Sales Growth % Change
Mar2025 12.77
544.95
Mar2024 1.98
Positive
Mar2023 -5.86
Negative
Mar2022 12.44
336.49
Mar2021 2.85 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Net Sales Growth ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹61,237.4 Cr 2.5% 7.7% 60.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,000.0 Cr -0.4% 5.3% 13.4% Stock Analytics
DIVIS LABORATORIES ₹161,076.0 Cr -4.3% -6.3% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,510.0 Cr 0.4% 8.2% 44.7% Stock Analytics
DR REDDYS LABORATORIES ₹107,921.0 Cr 0.5% 1.8% 16.4% Stock Analytics
CIPLA ₹106,150.0 Cr -0.8% -2.6% -9.2% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

2.5%

7.7%

60.5%

SENSEX

-5.5%

-11.5%

0.3%


You may also like the below Video Courses